Baird Medical Investment Holdings (BDMD) Notes Payables (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has 3 years of Notes Payables data on file, last reported at $10.4 million in Q4 2025.

• On a quarterly basis, Notes Payables fell 35.47% year-over-year to $10.4 million in Q4 2025; TTM through Dec 2025 was $10.4 million, a 35.47% decrease from a year earlier, with the FY2025 full-year figure at $10.4 million, down 35.47% from the prior year.
• Notes Payables for Q4 2025 stood at $10.4 million, down from $14.0 million in the prior quarter.
• Over the last five years, Notes Payables for BDMD reached as high as $16.2 million in Q4 2024 and fell as low as $8.2 million in Q4 2023.
• Historically, Notes Payables has averaged $12.2 million across 3 years, with a median of $12.2 million in 2025.
• Across the five-year window, Notes Payables surged 97.96% in 2024 and tumbled 35.47% in 2025, its largest moves.
• Year by year, Notes Payables stood at $8.2 million in 2023, then jumped by 97.96% to $16.2 million in 2024, then tumbled by 35.47% to $10.4 million in 2025.
• Per Business Quant data, the three most recent Notes Payables figures were $10.4 million in Q4 2025, $14.0 million in Q2 2025, and $16.2 million in Q4 2024.